For Research Purposes Only
Peptides

Tesamorelin

★★★★★ 4.7 (18 reviews)
Free shipping

$65.00

10mg · lyophilized · research use only

Earn 650 points with this purchase

45 in stock

Dosage$65.00
Quantity
1

BUNDLE & SAVE

SINGLE
1 VIAL$65.00$65.00/vial
2+1 FREE
2 VIALS+
1 free$130.0033% off
BEST DEAL
3 VIALS+
2 free
+ BAC Water
$195.0040% off
CoA
Sign Up & Save
We accept
VisaDiscoverAmerican ExpressCash AppZelle
SKU: T3608 Category:
Free shipping
Free shipment protection
1-2 day shipping available
Free shipping on all orders
Damage protection Included on all orders
Secure checkout 256-bit SSL

Certificate of Analysis

Independently 3× tested by Kovera Labs — verifying identity, purity, and net content.

Pending3× Tested
—PurityAwaiting results
VariantTesamorelin
Lot #—
Labeled—
Actual—
Tested—
Full QC PanelPending
Purity (HPLC)—
Net Content—
Identity (LC-MS)—
Lab report in progress

Tesamorelin is a stabilized synthetic analog of growth-hormone-releasing hormone (GHRH), studied for growth-hormone secretion and visceral-fat metabolism in research models. Each vial contains 10mg of lyophilized powder, third-party tested for identity and purity. For research use only — not for human consumption.

dosage

10MG

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin”

Your email address will not be published. Required fields are marked *

Compound Information

Technical specifications

MOLECULAR PROFILE

What Is Tesamorelin?

FormLyophilized powder
Research GradeThird-party verified
STORAGE REQUIREMENTS

Stability Information

Avoid freeze/thaw cycles Protect from light Keep refrigerated
Lyophilized (powder)−20°C · 24+ months
Reconstituted2–8°C · ~30 days

About Tesamorelin

  • Lyophilised powder, shipped sealed. Store refrigerated and protect from light.
  • Supplied for laboratory research use only. Not for human or veterinary use.

The GENIX Standard

  • Free shipping on every order, with no minimum.
  • Tracked delivery on every order, discreetly packaged.
  • Certificates of analysis published per lot and linked from the product page.
  • Checkout by card or Apple Pay.
  • Research-use labelling on every vial, with no therapeutic claims made anywhere on this site.

Community Reviews

4.7 ★★★★★ Based on 18 reviews of GENIX
5 ★ 13
4 ★ 5
3 ★ 0
2 ★ 0
1 ★ 0
★★★★★

Shipping was crazy fast, got my order way sooner then expected. I also like that they have 3rd party testing available, makes the whole process feel alot more transparent. Packaging was good too.

JMJake M.
★★★★★

Really happy with the customer service. Had a question about my order and they got back to me super quick. Free shipping was also a nice bonus, didnt expect that.

STSarah T.
★★★★☆

Order came fast and everything was packaged really good. The 3rd party lab results being posted was a big reason I decided to try them. Website could be a little easier to navigate tho.

MRMike R.
★★★★★

Honestly impressed. Free shipping, quick processing and good communication thru the whole order. Customer service answered my questions without making me wait forever lol.

AKAmanda K.
★★★★★

Very smooth order from start to finish. Tracking was sent right away and package arrived quicker then I thought. I like seeing the independent testing info too, gives me more confidence in the company.

CBChris B.
★★★★★

These guys ship FAST. Ordered and had tracking basically right away. Packaging was discreet and secure, no complaints here.

TSTyler S.

Reviews are of GENIX as a supplier, not of this individual compound.

You may also like

More research-grade compounds

Sources & References

Peer-reviewed research

NEW ENGLAND JOURNAL OF MEDICINE

Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIV

2007 Falutz J, et al.
View Source ↗
JAMA

Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients with Abdominal Fat Accumulation — A Randomized Clinical Trial

2014 Stanley TL, et al.
View Source ↗
J. CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of Tesamorelin (TH9507) in Patients with Excess Abdominal Fat — Pooled Analysis of Two Phase 3 Trials

2010 Falutz J, et al.
View Source ↗
CLINICAL INFECTIOUS DISEASES

Reduction in Visceral Adiposity Is Associated with an Improved Metabolic Profile in Patients Receiving Tesamorelin

2012 Stanley TL, et al.
View Source ↗
PLOS ONE

Safety and Metabolic Effects of Tesamorelin in Patients with Type 2 Diabetes — A Randomized, Placebo-Controlled Trial

2017 Clemmons DR, et al.
View Source ↗
AIDS

Efficacy and Safety of Tesamorelin in People with HIV on Integrase Inhibitors

2024 Russo SC, et al.
View Source ↗